First Hybrid HOPE meeting in Bangkok, Thailand - a report
Highlights of Past EHA (HOPE) Asia 2022
September 2-3, 2022 – Bangkok, Thailand
A Almeida, President, European Hematology Association (EHA)
G Gaidano, Chair Global Outreach Committee, European Hematology Association (EHA)
P Rojnuckarin, President, Thai Society of Hematology (TSH)
S Hongeng, Vice President, Thai Society of Hematology (TSH)
B Pongtanakul, Co-Chair Scientific Committee, Thai Society of Hematology (TSH)
The beautiful city of Bangkok, with its gorgeous architectures, delicious cuisine and charming traditions were the perfect backdrop for the kick-off of the first hybrid HOPE Asia 2022.
On Friday September 1, EHA, the Thai Society of Hematology (TSH) and the faculty members were joined by 75+ hematologists in the Bangkok Convention Centre at Central World and over 175 attendees joint virtually – a great start of what turned out to be an excellent meeting!
After warm welcome words of EHA and TSH, and a beautiful traditional Thai ceremony, it was time to dive into the meeting. On the first day attendees heard the repeat presentations of the EHA2022 Hybrid Congress, focusing on lymphoid malignancies, acute leukemias, and red cell disorders & bone marrow failures. In addition, exclusively for the HOPE Asia meeting, Dr U Anurathapan presented on “Cellular Therapy in Pediatric Leukemias” and Dr A Taher on “Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management”. The first meeting day demonstrated the importance of bringing key messages, tailored to the needs of the local hematologist from various fields of hematology of the EHA2022 Congress to Asia.
The second day commenced with the Regional Joint Symposium: Thalassemia registry and regional perspectives. The session with presentations by Dr N Teawtrakul (Thailand), M Rahman (Bangladesh), R Kar (India), V Selvaratnam (Malaysia), N Ali (Pakistan), R De Castro (Philippines) and A Amaresena (Sri Lanka), turned out to be one of the most valued session. The regional symposium was followed by sessions on multiple myeloma, Myelodysplastic Syndromes (MD)/Myeloproliferative Neoplasms (MPN), and thrombosis.
“I thought the session on the different regional countries' registries was excellent and I learned a lot. I would love the opportunity to attend again in future”- HOPE Asia Faculty
A few quotes from our virtual audience:
The partners of HOPE Asia contributed by identifying and attending to the hematological needs of their respective country and region whilst composing the program. In addition, the partners recommended talented and enthusiastic chairs for each session and a selection of great regional experts who gave their presentation in the Regional Joint Symposium, which was very well received.
EHA would like to thank the partners, sponsors, faculty, and attendees for their contribution in making HOPE Asia 2022 a great success.